CVE-2025-0416

April 1, 2025, 8:26 p.m.

8.9
High

Description

Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system.

Product(s) Impacted

Vendor Product Versions
Valmet
  • Dna
  • <C2023

Weaknesses

Common security weaknesses mapped to this vulnerability.

CWE-269
Improper Privilege Management
The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor.

*CPE(s)

Affected systems and software identified for this CVE.

Type Vendor Product Version Update Edition Language Software Edition Target Software Target Hardware Other Information
a valmet dna <C2023 / / / / / / /

CVSS Score

8.9 / 10

CVSS Data - 4.0

  • Attack Vector: ADJACENT
  • Attack Complexity: LOW
  • Attack Requirements: PRESENT
  • Privileges Required: LOW
  • User Interaction: NONE
  • Scope:
  • Confidentiality Impact: HIGH
  • Integrity Impact: HIGH
  • Availability Impact: HIGH
  • Exploit Maturity: NOT_DEFINED
  • CVSS:4.0/AV:A/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:N/AU:Y/R:U/V:D/RE:H/U:Amber

    View Vector String

Timeline

Published: April 1, 2025, 4:15 a.m.
Last Modified: April 1, 2025, 8:26 p.m.

Status : Awaiting Analysis

CVE has been recently published to the CVE List and has been received by the NVD.

More info

Source

db4dfee8-a97e-4877-bfae-eba6d14a2166

*Disclaimer: Some vulnerabilities do not have an associated CPE. To enhance the data, we use AI to infer CPEs based on CVE details. This is an automated process and might not always be accurate.